Anonymous
Guest
Anonymous
Guest
Cutting down to single covered territories in the fall. Biogen keeping product from blowing It out. No need or dual covered territories.
If your religated to last line therapy based upon risk/benefit/work from the physician/patient perspective, why wouldn't you restructure?
Troll quit posting on here. Gilenya is the one product that is making Novartis a lot of $$ and there are a couple new possible indications coming later this year. And you think they will cut an already small salesforce? Use your head. The only ones getting cut this year are Gen Meds oh and maybe Hospital. Quit stirring the pot loser
Classic defense mechanism. Ignore reality and the unstable history of Novartis. Long around you fool. MS is only Novartis division with Pods. Those days are numbered and that's fact. Just watch
Biogen's Tecfidera is now the top oral MS therapy and is blunting Gilenya's growth. It also is cheaper in cost, which Biogen can leverage along with Tysabri with payers.
Classic defense mechanism. Ignore reality and the unstable history of Novartis. Long around you fool. MS is only Novartis division with Pods. Those days are numbered and that's fact. Just watch
I agree with #8, this guy is just trying to stir the pot. Gilenya, for all its troubles, is the one franchise that is doing very well in terms of ROI for NVS. Over a billion dollars and soon to be more if those new indications are approved. Yes Tec is kicking butt but a billion is still a billion.
Ok either you nimrods are all independently wealthy or just plain suicidal. Why are you wishing for MS to cuts it's already small salesforce in half? And for those with a brain why the f$&@ would NVS do that in the eve of 2 new indications with over 2 billion in potential?
Open you eyes pal....... Love these clueless reps who don't see reality and think they are safe.
Okay.... Pal... Then explain in business language why this would make sense?? Again the info I have is we have 2 billion dollar indications coming up. And you think NVS will cut a 100 rep salesforce in half? Okay... What info do you have to retort this? And please don't just say well they should? Use business sense or logic please. Okay your turn
Put your crack pipe down son. Look at the Pharma model that's been in place for last couple of years...... He'll look at what's happen under our eyes at Novartis in recent years. Open your eyes son, it's for your own good.